Dr. Luqman K. Dad, MD

Dr. Dad practices at Columbia University Irving Medical Center in New York, New York.

Dr. Dad's NPI, 1013136886, was assigned on April 24, 2007. Dr. Dad graduated from Boston University School Of Medicine in 2006. Dr. Dad's New York license number on file is 319664.

Dr. Dad's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Dad's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Dad is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Dad to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dad practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Dad's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Dad is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Dad's licenses on file in 2 states: New York and Maryland.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Dad treats.

CMS data shows 508 Medicare services from Dr. Dad across 10 procedure codes in 2024, for 62 Medicare patients. Medicare paid $43,578 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Dad in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dad's median patient age at 73, with 35% women.

In 2024, Dr. Dad wrote 76 Medicare Part D claims for 23 patients. 87% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $244 in total drug cost. In 2022, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dad for performance year 2024, reported through an alternative payment model (APM). Dr. Dad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dad as offering telehealth.

Dmand AI links 7 papers to Dr. Dad, published from 2010 to 2016. The most frequent topics are Radiation Oncology, Developing Countries and Internship and Residency. Dr. Dad has published most often in Int J Radiat Oncol Biol Phys. Dr. Dad's most frequent co-authors are Johnny R. Bernard, MD, Brandon J. Fisher, DO and Vinai Gondi, MD.

CMS Open Payments shows 86 general payments to Dr. Dad from 35 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 43% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,085.

Dr. Dad graduated from Boston University School Of Medicine in 2006.

Dr. Dad is in network with 7 carriers, including Aetna, MVP Health Care and Cigna. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.